117 related articles for article (PubMed ID: 29415639)
1. Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients.
Ma M; Zhao R; Yang X; Zhao L; Liu L; Zhang C; Wang X; Shan B
Hematology; 2018 Sep; 23(8):448-455. PubMed ID: 29415639
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of Mda-7/IL-24 and C-myb expression in tumor tissues of patients with diffuse large B cell lymphoma.
Ma M; Zhao R; Yang X; Zhao L; Liu L; Zhang C; Wang X; Shan B
Exp Ther Med; 2018 Aug; 16(2):649-656. PubMed ID: 30112030
[TBL] [Abstract][Full Text] [Related]
3. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.
Valencia-Hipόlito A; Hernández-Atenógenes M; Vega GG; Maldonado-Valenzuela A; Ramon G; Mayani H; Peña Alonso Y; Martinez-Maza O; Méndez-Tenorio A; Huerta-Yepez S; Bonavida B; Vega MI
Leuk Lymphoma; 2014 Aug; 55(8):1806-14. PubMed ID: 24067139
[TBL] [Abstract][Full Text] [Related]
4. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
Wang M; Yang W; Li M; Li Y
Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
[TBL] [Abstract][Full Text] [Related]
5. Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.
Hwang I; Go H; Jeon YK; Ko YH; Yoon DH; Suh C; Huh JR; Lee H; Gil M; Park CS
Virchows Arch; 2011 Oct; 459(4):353-9. PubMed ID: 21814778
[TBL] [Abstract][Full Text] [Related]
6. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults.
Song JY; Venkataraman G; Fedoriw Y; Herrera AF; Siddiqi T; Alikhan MB; Kim YS; Murata-Collins J; Weisenburger DD; Liu X; Duffield AS
Leuk Lymphoma; 2016; 57(4):866-71. PubMed ID: 26450341
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
[TBL] [Abstract][Full Text] [Related]
8. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
[TBL] [Abstract][Full Text] [Related]
9. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
[TBL] [Abstract][Full Text] [Related]
10. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
[TBL] [Abstract][Full Text] [Related]
12. [Mean level of expression of c-myb gene in leukaemia of children].
Szmyd K; Chaber R; Fiszer-Maliszewska L; Reich A; Grotthus E; Weclawek-Tompol J; Chybicka A
Med Wieku Rozwoj; 2006; 10(3 Pt 1):587-93. PubMed ID: 17317889
[TBL] [Abstract][Full Text] [Related]
13. Cytologic diagnosis of Burkitt lymphoma.
Troxell ML; Bangs CD; Cherry AM; Natkunam Y; Kong CS
Cancer; 2005 Oct; 105(5):310-8. PubMed ID: 15986398
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.
Tichý M; Knopfová L; Jarkovský J; Pekarčíková L; Veverková L; Vlček P; Katolická J; Čapov I; Hermanová M; Šmarda J; Beneš P
Tumour Biol; 2016 Aug; 37(8):10723-9. PubMed ID: 26873484
[TBL] [Abstract][Full Text] [Related]
15. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
16. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs.
Ma M; Zhao L; Sun G; Zhang C; Liu L; Du Y; Yang X; Shan B
Oncol Rep; 2016 May; 35(5):3122-30. PubMed ID: 26883473
[TBL] [Abstract][Full Text] [Related]
17. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex.
Dai YH; Hung LY; Chen RY; Lai CH; Chang KC
Transl Res; 2016 Sep; 175():129-143.e13. PubMed ID: 27150054
[TBL] [Abstract][Full Text] [Related]
18. Childhood non-Hodgkin's lymphoma: prognostic relevance of clinical stages and histologic subgroups.
Gasparini M; Lombardi F; Gianni C; Lattuada A; Rilke F; Fossati-Bellani F
Am J Pediatr Hematol Oncol; 1983; 5(2):161-71. PubMed ID: 6412581
[TBL] [Abstract][Full Text] [Related]
19. Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.
Trzeciecka A; Klossowski S; Bajor M; Zagozdzon R; Gaj P; Muchowicz A; Malinowska A; Czerwoniec A; Barankiewicz J; Domagala A; Chlebowska J; Prochorec-Sobieszek M; Winiarska M; Ostaszewski R; Gwizdalska I; Golab J; Nowis D; Firczuk M
Oncotarget; 2016 Jan; 7(2):1717-31. PubMed ID: 26636537
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
